Cognitive and environmental interventions to encourage healthy eating: evidence-based recommendations for public health policy.
Lindsay A WalkerChristopher D ChambersHarm VelingNatalia S LawrencePublished in: Royal Society open science (2019)
Policymakers are focused on reducing the public health burden of obesity. The UK average percentage of adults classified as obese is 26%, which is double that of the global average. Over a third of UK adults report using at least one weight management aid. Yet, many people still struggle to change their diet-related behaviour, despite having the awareness, intention and capability to do so. This 'intention-behaviour gap' may be because most existing dietary-choice interventions focus on individual decision-making, ignoring the effects of environmental cues on human behaviour. Behaviour change interventions that 'nudge' people into making healthier choices by modifying the food environment have been shown to be effective. However, this type of intervention is typically challenging for policymakers to implement for economic, ethical and public accessibility reasons. To overcome these concerns, policymakers should consider 'boosting' interventions. Boosting involves enhancing competences that help people make decisions consistent with their goals. Here, we outline cognitive training as a boosting intervention to tackle obesity. We synthesize the evidence for one type of cognitive training (go/no-go training) that may be effective at modifying food-related decisions and reducing body weight. We offer evidence-based recommendations for an obesity-focused Public Health Wales behaviour change programme.
Keyphrases
- public health
- weight loss
- physical activity
- metabolic syndrome
- body weight
- bariatric surgery
- insulin resistance
- decision making
- type diabetes
- weight gain
- global health
- randomized controlled trial
- human health
- high fat diet induced
- endothelial cells
- adipose tissue
- body mass index
- virtual reality
- cross sectional
- emergency department
- clinical practice
- risk assessment
- life cycle
- obese patients
- clinical trial
- skeletal muscle
- adverse drug